The Central Epidemic Command Center (CECC) on Wednesday publicized regulations on the use of the oral antiviral pill molnupiravir, made by drugmaker Merck, which has been granted emergency use authorization (EUA) in Taiwan.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Cross-Strait
KMT caucus whip heads to Beijing to discuss cross-strait ties
04/26/2024 06:24 PM - Sports
Rakuten Monkeys' renovated stadium opener postponed due to rain
04/26/2024 05:57 PM - Business
Gaming console industry gives Taiwan huge business opportunities: Tsai
04/26/2024 05:48 PM - Business
Taiwan's 2024 GDP growth forecast raised to 3.29% due to AI boom
04/26/2024 04:55 PM - Politics
Visiting Ukrainian NGOs call for more support from Taiwan
04/26/2024 04:48 PM